These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 30275230)

  • 21. Survivin expression and serum levels in pancreatic cancer.
    Dong H; Qian D; Wang Y; Meng L; Chen D; Ji X; Feng W
    World J Surg Oncol; 2015 May; 13():189. PubMed ID: 26016480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma.
    Cheng ZJ; Hu LH; Huang SJ
    Ai Zheng; 2008 Mar; 27(3):258-63. PubMed ID: 18334114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survivin gene promoter polymorphism -31G/C as a risk factor for keratocystic odontogenic tumor development.
    Andric M; Nikolic N; Boskovic M; Milicic B; Skodric S; Basta Jovanovic G; Milasin J
    Eur J Oral Sci; 2012 Feb; 120(1):9-13. PubMed ID: 22288915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitatively determined survivin expression levels are of prognostic value in human gliomas.
    Chakravarti A; Noll E; Black PM; Finkelstein DF; Finkelstein DM; Dyson NJ; Loeffler JS
    J Clin Oncol; 2002 Feb; 20(4):1063-8. PubMed ID: 11844831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional expression of survivin and its splice variants in brain tumors in humans.
    Yamada Y; Kuroiwa T; Nakagawa T; Kajimoto Y; Dohi T; Azuma H; Tsuji M; Kami K; Miyatake S
    J Neurosurg; 2003 Oct; 99(4):738-45. PubMed ID: 14567610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Caspase-9 Gene Ex5+32 G>A (rs1052576) Variant in Susceptibility to Primary Brain Tumors.
    Ozdogan S; Kafadar A; Yilmaz SG; Timirci-Kahraman O; Gormus U; Isbir T
    Anticancer Res; 2017 Sep; 37(9):4997-5000. PubMed ID: 28870924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India.
    Upadhyay R; Khurana R; Kumar S; Ghoshal UC; Mittal B
    Ann Surg Oncol; 2011 Mar; 18(3):880-7. PubMed ID: 20957442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
    Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
    Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survivin promoter polymorphism and cervical carcinogenesis.
    Borbély AA; Murvai M; Szarka K; Kónya J; Gergely L; Hernádi Z; Veress G
    J Clin Pathol; 2007 Mar; 60(3):303-6. PubMed ID: 16714396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility.
    Kawata N; Tsuchiya N; Horikawa Y; Inoue T; Tsuruta H; Maita S; Satoh S; Mitobe Y; Narita S; Habuchi T
    Int J Cancer; 2011 Oct; 129(8):1872-80. PubMed ID: 21154810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of CASP8 D302H Gene Variants in Patients with Primary Brain Tumors.
    Cacina C; Pence S; Turan S; Genc F; Ozdemir H; Kafadar A; Kaynar MY; Yaylim I
    In Vivo; 2015; 29(5):601-4. PubMed ID: 26359420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of single nucleotide polymorphisms in the coding region of Bcl-2 with the occurrence and prognosis of colorectal cancer: A case-control study.
    Huang B; Liu X; Sun C; Wang L; Yang L
    Cancer Biomark; 2017; 18(4):433-439. PubMed ID: 28106544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients.
    Farnebo L; Tiefenböck K; Ansell A; Thunell LK; Garvin S; Roberg K
    Int J Cancer; 2013 Oct; 133(8):1994-2003. PubMed ID: 23564498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular detection of survivin expression, antiapoptotic gene, and other prognostic markers, how they are correlated and how it could be of prognostic value in chronic myeloid leukemia patient.
    Zhara M; Mourad H; Farouk G; Elbatch M; Ezzat S; Sami W
    Egypt J Immunol; 2007; 14(2):51-62. PubMed ID: 20306657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between rs9904341 GQin L; Yu T
    Genet Mol Res; 2015 May; 14(2):5197-202. PubMed ID: 26125713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survivin polymorphism is associated with disease activity in rheumatoid arthritis patients.
    Jenko B; Praprotnik S; Čučnik S; Rotar Ž; Tomšič M; Dolžan V
    Pharmacogenomics; 2016; 17(1):45-9. PubMed ID: 26651826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survivin: A molecular biomarker in cancer.
    Jaiswal PK; Goel A; Mittal RD
    Indian J Med Res; 2015 Apr; 141(4):389-97. PubMed ID: 26112839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of IL17A and IL17F genes with rheumatoid arthritis disease and the impact of genetic polymorphisms on response to treatment.
    Marwa OS; Kalthoum T; Wajih K; Kamel H
    Immunol Lett; 2017 Mar; 183():24-36. PubMed ID: 28143790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of miR‑146aC>G, miR‑149C>T, miR‑196a2C>T and miR‑499A>G polymorphisms with brain tumors.
    Lim J; Kim JO; Park HS; Han IB; Kwack K; Kim NK; Cho K
    Oncol Rep; 2018 Sep; 40(3):1813-1823. PubMed ID: 30015947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.